Provided by Tiger Fintech (Singapore) Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

1.52
+0.05003.40%
Pre-market: 1.520.00000.00%09:11 EDT
Volume:96.46K
Turnover:144.15K
Market Cap:10.50M
PE:-0.63
High:1.54
Open:1.48
Low:1.48
Close:1.47
Loading ...

Intelligent Bio Solutions to highlight drug testing tech at 2025 NDASA

TIPRANKS
·
28 Mar

Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show

GlobeNewswire
·
28 Mar

BRIEF-Intelligent Bio Solutions Highlights Continued Expansion With Strategic Partnership In Spain And Andorra

Reuters
·
27 Mar

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

GlobeNewswire
·
27 Mar

BRIEF-Intelligent Bio Solutions Granted U.S. Patent For Fingerprinting Drug Screening Cartridge

Reuters
·
26 Mar

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

GlobeNewswire
·
26 Mar

EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch

Benzinga
·
25 Mar

Intelligent Bio Solutions Expecting to Get US Patent to Enhance Protection of Lateral Flow Technology

MT Newswires Live
·
20 Mar

Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

GlobeNewswire
·
20 Mar

Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th

GlobeNewswire
·
11 Mar

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock

GlobeNewswire
·
22 Feb

BRIEF-Intelligent Bio Solutions Announces Proposed Public Offering Of Common Stock

Reuters
·
20 Feb

Intelligent Bio Solutions Second Quarter 2025 Earnings: US$0.50 loss per share (vs US$2.07 loss in 2Q 2024)

Simply Wall St.
·
15 Feb

Intelligent Bio Solutions Q2 EPS $(0.50) Up From $(2.07) YoY, Sales $607.49K Down From $764.06K YoY

Benzinga
·
13 Feb

Intelligent Bio releases shareholder letter on 2024 growth, 2025 strategy

TIPRANKS
·
10 Feb

Intelligent Bio says Avon selects Intelligent Fingerprinting Drug Testing tool

TIPRANKS
·
07 Feb

EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales

Benzinga
·
06 Feb